OZ277 Antimalarial Synthesis via Ozone Oxidation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimalarial drugs, such as synthetic artemisinin derivatives, face issues like recrudescence, neurotoxicity, and low oral activity, necessitating the development of new antimalarial agents that are easily synthesized and devoid of neurotoxicity.
Innovation Solution
A process for preparing compounds of Formula I, specifically cis-adamantane-2-spiro-3′-8′-[[[(2′-amino-2′-methyl propyl)amino]carbonyl]methyl]-1′,2′,4′-trioxaspiro[4.5]decane, which involves fewer reaction steps, higher yields, reduced reaction times, and avoids the use of costly and toxic chemicals like pyridine, with direct product isolation by filtration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional synthesis methods are used to prepare antimalarial compounds, then the compounds can be produced, but the process requires multiple reaction steps, uses costly and toxic chemicals, and has low yield
Solution Approach 1:
The patent combines multiple reaction steps into a single step by reacting a hydroxylamine derivative with a spiroketone in one operation to directly form the trioxolane product. This merging of steps reduces complexity while improving yield and eliminating the need for separate protection/deprotection steps.
Solution Approach 2:
The patent extracts and eliminates toxic chemicals like pyridine from the synthesis process. By using alternative reagents and conditions, the method removes harmful substances while maintaining or improving synthesis efficiency and safety.
2Productivity
If conventional synthesis methods are used, then compounds can be prepared, but the process is time-consuming and uses toxic chemicals
Solution Approach 1:
The patent removes toxic chemicals such as pyridine from the synthesis process by using alternative reagents. This extraction of harmful substances reduces toxicity while maintaining synthesis efficiency and improving safety.
Solution Approach 2:
The patent changes reaction parameters including temperature, solvent choice, and reagent selection to achieve faster reaction times. By optimizing these parameters, the method reduces reaction time while eliminating toxic chemicals from the process.
3Reliability
If existing antimalarial drugs are used, then antimalarial activity is achieved, but neurotoxicity and recrudescence occur
Solution Approach 1:
The patent converts the harmful effect of neurotoxicity into a benefit by designing synthesis methods that inherently avoid toxic reagents. The new approach uses benign chemicals and conditions that eliminate neurotoxicity while maintaining or improving antimalarial activity through optimized molecular structures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process results in high-yield, cost-effective production of antimalarial compounds with improved synthesis efficiency and reduced neurotoxicity, addressing the limitations of existing antimalarial drugs.
Implementation Method 1
The reaction mixture is treated with ozone to effect oxidation
Data Source
AI summary
This invention relates to an improved process for the preparation of a compound of Formula (I), salts of the free base cis-adamantane-2-spiro-3′-8′-[[[(2′-amino-2′-methyl propyl)amino]carbonyl]methyl]-1′,2′,4′-trioxaspiro[4.5]decane wherein X can be an anion.